Article Information
History
- August 19, 2021.
Article Versions
- Version 1 (September 11, 2020 - 15:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Michael J. Kratochvil1,2,#,
- Gernot Kaber1,#,
- Pamela C. Cai3,
- Elizabeth B. Burgener4,
- Graham L. Barlow1,
- Mark R. Nicolls5,
- Michael G. Ozawa6,
- Donald P. Regula6,
- Ana E. Pacheco-Navarro5,
- Carlos E. Milla4,
- Nadine Nagy1,
- Samuel Yang7,
- Stanford COVID-19 Biobank Study Group,
- Angela J. Rogers5,*,
- Andrew J. Spakowitz3,*,
- Sarah C. Heilshorn2,* and
- Paul L. Bollyky1,*,†
- 1Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305
- 2Department of Materials Science and Engineering, Stanford University, 476 Lomita Mall, Stanford, CA 94305
- 3Department of Chemical Engineering, Stanford University, 443 Via Ortega, Stanford, CA 94305
- 4Center for Excellence in Pulmonary Biology, Department of Pediatrics, Stanford University, 770 Welch Road, Stanford, CA 94305
- 5Department of Pulmonology and Critical Care Medicine, Stanford University School of Medicine, Lane 235, 300 Pasteur Drive, Stanford, CA 94305
- 6Department of Pathology, Stanford University School of Medicine, Lane 235, 300 Pasteur Drive, Stanford, CA 94305
- 7Department of Emergency Medicine, Stanford University School of Medicine, Always Building, MC5119, 300 Pasteur Drive, Stanford, CA 94305
- ↵†Correspondence to: Paul Bollyky, MD, PhD: Department of Medicine, Division of Infectious Diseases, Stanford University, 279 Campus Drive, Beckman Center, Stanford CA 94305, USA. pbollyky{at}stanford.edu